Cargando…
Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients
Background: Lung cancer is among the most dangerous malignant tumors to human health. Lung adenocarcinoma (LUAD) accounts for about 40% of all lung cancers. Accumulating evidence suggests that the tumor microenvironment (TME) is a crucial regulator of carcinogenesis and therapeutic efficacy in LUAD....
Autores principales: | Huang, Pinzheng, Xu, Linfeng, Jin, Mingming, Li, Lixi, Ke, Yizhong, Zhang, Min, Zhang, Kairui, Lu, Kongyao, Huang, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222903/ https://www.ncbi.nlm.nih.gov/pubmed/35741714 http://dx.doi.org/10.3390/genes13060951 |
Ejemplares similares
-
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment
por: Zhang, Fa-Peng, et al.
Publicado: (2020) -
Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
por: Xu, Linfeng, et al.
Publicado: (2021) -
Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2022) -
EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma
por: Deng, Mingming, et al.
Publicado: (2021) -
Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
por: Jiang, Fan, et al.
Publicado: (2022)